查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566959

動物幹細胞治療市場：按類型、類別、最終用戶：2024-2033 年全球機會分析與產業預測

Animal Stem Cell Therapy Market By Type (Allogenic, Autologous) , By Species (Dog, Cat, Horse) By End User (Veterinary Hospitals, Research Organizations) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

動物幹細胞治療市場

2023年動物幹細胞治療市值為2.56億美元，預計2024年至2033年複合年成長率為5.6%，2033年達4.4億美元。

動物幹細胞療法是治療方法。幹細胞是體內未分化的細胞，能夠產生不同功能的新細胞。幹細胞的這種能力對於修復受損的組織和器官至關重要。幹細胞是從身體的各個部位採集的，包括骨髓、臍帶血和脂肪組織。事實證明，這種治療方法可有效治療多種疾病，包括骨關節炎、神經系統疾病、肌腱和韌帶損傷以及各種自體免疫疾病。

全球寵物擁有量的增加以及寵物生活方式和健康支出的快速增加是動物幹細胞治療市場的關鍵驅動力。此外，動物中慢性疾病和健康相關疾病的盛行率不斷增加，推動了對幹細胞療法的需求。隨著科技的進步，將人工智慧引入幹細胞治療的趨勢日益明顯。事實證明，人工智慧是一種前所未有的工具，可以提高治療期間的準確性並解決併發症。該工具為設計各種程序提供了可靠的框架，包括對幹細胞集落進行分類、識別細胞形態、表徵癌症幹細胞中未描述的形態特徵以及預測藥物效果。

然而，動物幹細胞治療需要花費大量資金，因此預算有限的寵物飼主無法負擔這些治療費用。此外，圍繞幹細胞效用的倫理考量正在阻礙市場開拓。例如，歐洲藥品管理局針對獸醫幹細胞療法引入了嚴格的評估流程。

按部門審查

動物幹細胞治療市場按類型、物種、最終用戶和地區細分。依類型分為同種異體幹細胞療法和自體幹細胞療法。依種類分為狗、貓、馬。依最終使用者分為獸醫院和研究機構。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按類型分類，2023 年同種異體佔據最高市場佔有率。

從最終用戶來看，狗類細分市場在 2023 年將佔據較高的市場。

按地區分類，北美地區 2023 年收益最高。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 根據客戶興趣加入公司簡介

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第 4 章動物幹細胞治療：機會分析與產業預測，2024-2033 年市場（按類型）

  • 市場概況
  • 同種異體的
  • 自體的

第 5 章動物幹細胞治療：機會分析與產業預測，2024-2033 年市場（按最終用戶）

  • 市場概況
  • 狗
  • 貓
  • 馬

第 6 章動物幹細胞治療：機會分析與產業預測，2024-2033 年市場（按最終用戶）

  • 市場概況
  • 動物醫院
  • 研究所

第 7 章動物幹細胞治療：機會分析與產業預測，2024-2033 年市場（按地區）

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國動物幹細胞治療：2024-2033年市場機會分析與產業預測
    • 加拿大動物幹細胞治療：2024-2033 年市場機會分析與產業預測
    • 墨西哥動物幹細胞治療：2024-2033 年市場機會分析與產業預測
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國動物幹細胞療法：2024-2033年市場機會分析與產業預測
    • 德國動物幹細胞療法：2024-2033年市場機會分析與產業預測
    • 義大利動物幹細胞治療：2024-2033 年市場機會分析與產業預測
    • 西班牙動物幹細胞療法：2024-2033年市場機會分析與產業預測
    • 英國動物幹細胞療法：2024-2033年市場機會分析與產業預測
    • 其他歐洲動物幹細胞療法：2024-2033 年市場機會分析與產業預測
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國動物幹細胞治療：2024-2033年市場商機分析及產業預測
    • 日本動物幹細胞療法：2024-2033年市場機會分析與產業預測
    • 印度動物幹細胞療法：2024-2033 年市場機會分析與產業預測
    • 韓國動物幹細胞治療：2024-2033年市場機會分析與產業預測
    • 澳洲動物幹細胞療法：2024-2033年市場機會分析與產業預測
    • 其他亞太地區動物幹細胞療法：2024-2033 年市場機會分析與產業預測
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西動物幹細胞治療：2024-2033年市場機會分析與產業預測
    • 南非動物幹細胞治療：2024-2033 年市場機會分析與產業預測
    • 沙烏地阿拉伯動物幹細胞治療：2024-2033年市場機會分析與產業預測
    • 其他拉丁美洲/中東/非洲地區的動物幹細胞治療：2024-2033年市場機會分析與產業預測

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Aratana Therapeutics, Inc.
  • VetStem, Inc.
  • Regeneus Ltd.
  • Magellan Stem Cells
  • PrimeGen Biotech, LLC
  • Vetbiologics
  • Boehringer Ingelheim
  • Cell Therapy Sciences
  • VETherapy Corporation
  • MediVet Biologics LLC
簡介目錄
Product Code: A324363

Animal Stem Cell Therapy Market

The animal stem cell therapy market was valued at $256.0 million in 2023 and is projected to reach $440.0 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Animal stem cell therapy is a procedure which involves the usage of stem cells to treat injuries or cure diseases in animals. Stem cells are the undifferentiated cells inside a living body which possess the capacity to give rise to new cells with different functionalities. This ability of stem cells makes them essential for the repair of damaged tissues and organs. To perform the therapy, the stem cells are harvested from diverse body parts, including bone marrow, umbilical cord blood, or fat tissue. The therapy has proven to be beneficial in the treatment of different conditions such as osteoarthritis, neurological disorders, tendon & ligament injuries, and various autoimmune diseases.

Increase in the ownership of pets globally, along with surge in expenditure on their lifestyle and health is a key driver of the animal stem cell therapy market. In addition, prevalence of chronic diseases and health-related disorders is rising among animals, thereby boosting the demand for stem cell therapy. With progressing technology, the trend of integrating AI in stem cell therapy is gaining prominence. AI is proving to be an unprecedented tool for achieving precision and addressing complications during the treatment. The tool helps to design a reliable framework for different procedures, including classification of stem cells colony, identification of cellular morphology, characterization of undescribed morphological traits in cancer stem cells, and prediction of drug effects.

However, the costs of animal stem cell therapies are significantly high, restricting the pet owners with limited budgets from affording such treatments. In addition, the market development is hampered by the ethical considerations surrounding the utility of stem cells, as compliance with such regulations is an intricate and lengthy procedure. For instance, the European Medicines Agency has implemented a rigorous evaluation process pertaining to stem cell therapies for veterinary use.

Segment Review

The animal stem cell therapy market is segmented into type, species, end user, and region. On the basis of type, the market is bifurcated into allogenic and autologous. As per species, it is divided into dog, cat, and horse. Depending on end user, it is classified into veterinary hospitals and research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the allogenic segment accounted for the highest market share in 2023.

As per species, the dog segment acquired high stakes in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global animal stem cell therapy market include Aratana Therapeutics, Inc., VetStem, Inc., Regeneus Ltd., Magellan Stem Cells, PrimeGen Biotech, LLC, Vetbiologics, Boehringer Ingelheim, Cell Therapy Sciences, VETherapy Corporation, and MediVet Biologics LLC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Allogenic
  • Autologous

By Species

  • Dog
  • Cat
  • Horse

By End User

  • Veterinary Hospitals
  • Research Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Aratana Therapeutics, Inc.
    • VetStem, Inc.
    • Regeneus Ltd.
    • Magellan Stem Cells
    • PrimeGen Biotech, LLC
    • Vetbiologics
    • Boehringer Ingelheim
    • Cell Therapy Sciences
    • VETherapy Corporation
    • MediVet Biologics LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Allogenic
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Autologous
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY SPECIES

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Species
  • 5.2. Dog
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Cat
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Horse
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Veterinary Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Research Organizations
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Species
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Species
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Species
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Species
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Species
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Species
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Species
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Species
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Species
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Species
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Species
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Species
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Species
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Species
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Species
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Species
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Species
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Species
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Species
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Species
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Species
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Species
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Species
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Aratana Therapeutics, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. VetStem, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Regeneus Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Magellan Stem Cells
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. PrimeGen Biotech, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Vetbiologics
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Boehringer Ingelheim
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Cell Therapy Sciences
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. VETherapy Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. MediVet Biologics LLC
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments